scholarly journals BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells

2017 ◽  
Vol 7 (1) ◽  
pp. 184-195 ◽  
Author(s):  
Ke-Hung Tsui ◽  
Kun-Chun Chiang ◽  
Yu-Hsiang Lin ◽  
Kang-Shuo Chang ◽  
Tsui-Hsia Feng ◽  
...  
Cancers ◽  
2019 ◽  
Vol 12 (1) ◽  
pp. 10 ◽  
Author(s):  
Yu-Hsiang Lin ◽  
Ke-Hung Tsui ◽  
Kang-Shuo Chang ◽  
Chen-Pang Hou ◽  
Tsui-Hsia Feng ◽  
...  

Maspin is a member of the clade B serine protease inhibitor superfamily and exhibits diverse regulatory effects in various types of solid tumors. We compared the expressions of maspin and determined its potential biological functions and regulatory mechanisms in bladder carcinoma cells in vitro and in vivo. The results of RT-qPCR indicated that maspin expressed significantly lower levels in the bladder cancer tissues than in the paired normal tissues. The immunohistochemical assays of human bladder tissue arrays revealed similar results. Maspin-knockdown enhanced cell invasion whereas the overexpression of maspin resulted in the opposite process taking place. Knockdown of maspin also enhanced tumorigenesis in vivo and downregulated protein levels of acetyl-histone H3. Moreover, in bladder carcinoma cells, maspin modulated HDAC1 target genes, including cyclin D1, p21, MMP9, and vimentin. Treatment with MK2206, which is an Akt inhibitor, upregulated maspin expression, whereas PTEN-knockdown or PTEN activity inhibitor (VO-OHpic) treatments demonstrated reverse results. The ectopic overexpression of p53 or camptothecin treatment induced maspin expression. Our study indicated that maspin is a PTEN-upregulated and p53-upregulated gene that blocks cell growth in vitro and in vivo, and may act as an HDAC1 inhibitor in bladder carcinoma cells. We consider that maspin is a potential tumor suppressor gene in bladder cancer.


1991 ◽  
Vol 88 (12) ◽  
pp. 5257-5261 ◽  
Author(s):  
R. Takahashi ◽  
T. Hashimoto ◽  
H. J. Xu ◽  
S. X. Hu ◽  
T. Matsui ◽  
...  

BMC Cancer ◽  
2010 ◽  
Vol 10 (1) ◽  
Author(s):  
Emilia Peuhu ◽  
Aura Kaunisto ◽  
Jarmo K Laihia ◽  
Lasse Leino ◽  
John E Eriksson

2002 ◽  
Vol 1565 (1) ◽  
pp. 112-122 ◽  
Author(s):  
Do Kyung Kim ◽  
Yoshikatsu Kanai ◽  
Hye Won Choi ◽  
Sahatchai Tangtrongsup ◽  
Arthit Chairoungdua ◽  
...  

2007 ◽  
Vol 352 (2) ◽  
pp. 549-555 ◽  
Author(s):  
Mikael Herlevsen ◽  
Gary Oxford ◽  
Celeste Ptak ◽  
Jeffrey Shabanowitz ◽  
Donald F. Hunt ◽  
...  

2019 ◽  
Vol 20 (19) ◽  
pp. 4946 ◽  
Author(s):  
Tsui ◽  
Lin ◽  
Chang ◽  
Hou ◽  
Chen ◽  
...  

Transgelin (TAGLN/SM22-α) is a regulator of the actin cytoskeleton, affecting the survival, migration, and apoptosis of various cancer cells divergently; however, the roles of TAGLN in bladder carcinoma cells remain inconclusive. We compared expressions of TAGLN in human bladder carcinoma cells to the normal human bladder tissues to determine the potential biological functions and regulatory mechanisms of TAGLN in bladder carcinoma cells. Results of RT-qPCR and immunoblot assays indicated that TAGLN expressions were higher in bladder smooth muscle cells, fibroblast cells, and normal epithelial cells than in carcinoma cells (RT-4, HT1376, TSGH-8301, and T24) in vitro. Besides, the results of RT-qPCR revealed that TAGLN expressions were higher in normal tissues than the paired tumor tissues. In vitro, TAGLN knockdown enhanced cell proliferation and invasion, while overexpression of TAGLN had the inverse effects in bladder carcinoma cells. Meanwhile, ectopic overexpression of TAGLN attenuated tumorigenesis in vivo. Immunofluorescence and immunoblot assays showed that TAGLN was predominantly in the cytosol and colocalized with F-actin. Ectopic overexpression of either p53 or PTEN induced TAGLN expression, while p53 knockdown downregulated TAGLN expression in bladder carcinoma cells. Our results indicate that TAGLN is a p53 and PTEN-upregulated gene, expressing higher levels in normal bladder epithelial cells than carcinoma cells. Further, TAGLN inhibited cell proliferation and invasion in vitro and blocked tumorigenesis in vivo. Collectively, it can be concluded that TAGLN is an antitumor gene in the human bladder.


2007 ◽  
Vol 149 ◽  
pp. S83
Author(s):  
Takeshi Kumagai ◽  
Yuichi Yajima ◽  
Yosuke Kozakai ◽  
Yasuhito Nakagawa

2007 ◽  
Vol 67 (12) ◽  
pp. 5896-5905 ◽  
Author(s):  
Patrick D. Sutphin ◽  
Denise A. Chan ◽  
James M. Li ◽  
Sandra Turcotte ◽  
Adam J. Krieg ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document